Cargando…
Universal selenium nanoadjuvant with immunopotentiating and redox-shaping activities inducing high-quality immunity for SARS-CoV-2 vaccine
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969362/ https://www.ncbi.nlm.nih.gov/pubmed/36849546 http://dx.doi.org/10.1038/s41392-023-01371-1 |
_version_ | 1784897703173423104 |
---|---|
author | Lai, Haoqiang Xu, Ligeng Liu, Chang Shi, Sujiang Jiang, Yalin Yu, Yangyang Deng, Bo Chen, Tianfeng |
author_facet | Lai, Haoqiang Xu, Ligeng Liu, Chang Shi, Sujiang Jiang, Yalin Yu, Yangyang Deng, Bo Chen, Tianfeng |
author_sort | Lai, Haoqiang |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9969362 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-99693622023-02-28 Universal selenium nanoadjuvant with immunopotentiating and redox-shaping activities inducing high-quality immunity for SARS-CoV-2 vaccine Lai, Haoqiang Xu, Ligeng Liu, Chang Shi, Sujiang Jiang, Yalin Yu, Yangyang Deng, Bo Chen, Tianfeng Signal Transduct Target Ther Letter Nature Publishing Group UK 2023-02-27 /pmc/articles/PMC9969362/ /pubmed/36849546 http://dx.doi.org/10.1038/s41392-023-01371-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Letter Lai, Haoqiang Xu, Ligeng Liu, Chang Shi, Sujiang Jiang, Yalin Yu, Yangyang Deng, Bo Chen, Tianfeng Universal selenium nanoadjuvant with immunopotentiating and redox-shaping activities inducing high-quality immunity for SARS-CoV-2 vaccine |
title | Universal selenium nanoadjuvant with immunopotentiating and redox-shaping activities inducing high-quality immunity for SARS-CoV-2 vaccine |
title_full | Universal selenium nanoadjuvant with immunopotentiating and redox-shaping activities inducing high-quality immunity for SARS-CoV-2 vaccine |
title_fullStr | Universal selenium nanoadjuvant with immunopotentiating and redox-shaping activities inducing high-quality immunity for SARS-CoV-2 vaccine |
title_full_unstemmed | Universal selenium nanoadjuvant with immunopotentiating and redox-shaping activities inducing high-quality immunity for SARS-CoV-2 vaccine |
title_short | Universal selenium nanoadjuvant with immunopotentiating and redox-shaping activities inducing high-quality immunity for SARS-CoV-2 vaccine |
title_sort | universal selenium nanoadjuvant with immunopotentiating and redox-shaping activities inducing high-quality immunity for sars-cov-2 vaccine |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969362/ https://www.ncbi.nlm.nih.gov/pubmed/36849546 http://dx.doi.org/10.1038/s41392-023-01371-1 |
work_keys_str_mv | AT laihaoqiang universalseleniumnanoadjuvantwithimmunopotentiatingandredoxshapingactivitiesinducinghighqualityimmunityforsarscov2vaccine AT xuligeng universalseleniumnanoadjuvantwithimmunopotentiatingandredoxshapingactivitiesinducinghighqualityimmunityforsarscov2vaccine AT liuchang universalseleniumnanoadjuvantwithimmunopotentiatingandredoxshapingactivitiesinducinghighqualityimmunityforsarscov2vaccine AT shisujiang universalseleniumnanoadjuvantwithimmunopotentiatingandredoxshapingactivitiesinducinghighqualityimmunityforsarscov2vaccine AT jiangyalin universalseleniumnanoadjuvantwithimmunopotentiatingandredoxshapingactivitiesinducinghighqualityimmunityforsarscov2vaccine AT yuyangyang universalseleniumnanoadjuvantwithimmunopotentiatingandredoxshapingactivitiesinducinghighqualityimmunityforsarscov2vaccine AT dengbo universalseleniumnanoadjuvantwithimmunopotentiatingandredoxshapingactivitiesinducinghighqualityimmunityforsarscov2vaccine AT chentianfeng universalseleniumnanoadjuvantwithimmunopotentiatingandredoxshapingactivitiesinducinghighqualityimmunityforsarscov2vaccine |